-
University, Startup Develop Low-Power, High-Impact Display
A collaboration between University of Cincinnati’s (UC’s) Novel Devices Laboratory, and startup company Gamma Dynamics LLC, also in Cincinnati, Ohio have created an electrofluidic display that provides a full color, high-impact image at a fraction of the power needed for current color hand-held and tablet devices. Electrofluidic displays use colored liquids to display the various…
-
Finnish Companies to Build Brazil R&D Center
VTT Technical Research Centre in Espoo, Finland and Kemira Oyj, a water-quality management company in Helsinki, are opening a new joint R&D center in São Paulo, Brazil, focusing on water chemistry and biomass. The center will open at the end of 2010. The São Paulo R&D center is expected to implement new water technology research…
-
Survey: University Startups, Products Keep Pace in 2009
The Association of University Technology Managers (AUTM), the association of institutional technology transfer professionals, released yesterday its 2009 licensing survey, showing the volume of startups and new products last year about the same as in 2008, but the number of new patents filed in the U.S. dropping. AUTM’s survey says personnel at universities, research institutes,…
-
Global Semiconductor Sales Rise in August
The Semiconductor Industry Association (SIA) reports today that worldwide semiconductor sales in August 2010 rose 1.8 percent to $25.7 billion, from $25.2 billion in July. Sales rose in all regions, with chip sales in Japan registering the largest increase of 4.1 percent followed by the sales in the Americas that rose 2 percent. Compared to…
-
Postdocs: Commercialization Important, But for Others
Post-doctoral researchers in the Washington, D.C. area recognize the importance of commercializing research, where scientific results can benefit the local economy, but most postdocs surveyed have little interest in running their own business once their research fellowship ends. That’s the finding of a study published in the current issue of the International Journal of Knowledge-Based…
-
FDA Okays Myelodysplastic Syndromes Trial Protocol
Onconova Therapeutics Inc., a biotech company in Newtown, Pennsylvania, says it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of a Phase 3 clinical trial for the company’s drug Estybon. The drug is a monotherapy for patients with myelodysplastic syndromes (MDS), diseases affecting…
-
N.C. State Patents Computer Chip Materials Technology
Researchers from North Carolina State University in Raleigh have patented technology that the developers say can change the global energy and communications infrastructure. The researchers, led by Jay Narayan, professor of materials science and engineering and co-holder of the patent, have developed the means to integrate gallium nitride (GaN) sensors and devices directly into silicon-based…
-
Safer Catalysts Developed for Power Plant Pollutants
A research team at Lehigh University in Bethlehem, Pennsylvania has developed catalysts that convert the harmful nitrogen oxides emitted from coal- and gas-fired power plants to nitrogen and water vapor. Unlike current methods, the catalysts developed with nanotechnology do not use ammonia or need high temperatures to work. Charles Lyman, professor of materials science and…
-
Stanford Univ. Licenses IVF Technology
Auxogyn Inc., a medical technology company in Menlo Park, California says it acquired an exclusive license from Stanford University to develop products that can help improve the effectiveness of in vitro fertilization (IVF) procedures. Auxogyn specializes in technologies for women’s reproductive health. A new paper describing the technology licensed from Stanford demonstrates that a human…
-
FDA Fast-Tracks Antibody for Inhalational Anthrax Treatment
Emergent BioSolutions Inc. in Rockville, Maryland says that its program for developing AVP-21D9, an antibody for the treatment of inhalational anthrax, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). Anthrax commonly affects hoofed animals such as sheep and goats, but also humans who come into contact with the infected…